Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 372,000 | 319,000 | 288,000 | 302,000 | 248,000 |
| Marketable Securities | 1,000 | 1,000 | 30,000 | 77,000 | 82,000 |
| Receivables | 272,000 | 287,000 | 271,000 | 281,000 | 258,000 |
| Inventories | 163,000 | 167,000 | 178,000 | 171,000 | 163,000 |
| Other current assets | 19,000 | 22,000 | 32,000 | 33,000 | 45,000 |
| TOTAL | $883,000 | $827,000 | $799,000 | $864,000 | $796,000 |
| Non-Current Assets | |||||
| PPE Net | 104,000 | 100,000 | 79,000 | 74,000 | 81,000 |
| Investments And Advances | 27,000 | 27,000 | 26,000 | 26,000 | 26,000 |
| Intangibles | 7,000 | 6,000 | 190,000 | 218,000 | 230,000 |
| Other Non-Current Assets | 355,000 | 355,000 | 370,000 | 353,000 | 320,000 |
| TOTAL | $493,000 | $488,000 | $665,000 | $671,000 | $657,000 |
| Total Assets | $1,375,000 | $1,316,000 | $1,464,000 | $1,535,000 | $1,453,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 18,000 | 18,000 | 3,000 | 3,000 | 3,000 |
| Accounts payable and accrued liabilities | 183,000 | 216,000 | 815,000 | 809,000 | 754,000 |
| Accrued Expenses | 780,000 | 661,000 | N/A | N/A | N/A |
| Other current liabilities | 3,000 | 11,000 | 124,000 | 182,000 | 88,000 |
| TOTAL | $1,005,000 | $924,000 | $962,000 | $1,012,000 | $861,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 311,000 | 315,000 | 235,000 | 235,000 | 235,000 |
| Other Non-Current Liabilities | 344,000 | 415,000 | 434,000 | 409,000 | 347,000 |
| TOTAL | $655,000 | $730,000 | $669,000 | $644,000 | $582,000 |
| Total Liabilities | $1,660,000 | $1,652,000 | $1,631,000 | $1,656,000 | $1,443,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 124,770 | N/A | N/A | N/A | N/A |
| Common Shares | 62,000 | 62,000 | 65,000 | 67,000 | 68,000 |
| Retained earnings | -406,000 | -443,000 | 1,070,000 | 1,124,000 | 1,256,000 |
| Other shareholders' equity | -34,000 | -46,000 | -1,315,000 | -1,323,000 | -1,325,000 |
| TOTAL | $-285,000 | $-337,000 | $-167,000 | $-121,000 | $10,000 |
| Total Liabilities And Equity | $1,375,000 | $1,315,000 | $1,464,000 | $1,535,000 | $1,453,000 |